Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.4M
-
Number of holders
-
99
-
Total 13F shares, excl. options
-
24M
-
Shares change
-
+314K
-
Total reported value, excl. options
-
$299M
-
Value change
-
+$4.22M
-
Number of buys
-
42
-
Number of sells
-
-43
-
Price
-
$12.49
Significant Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q2 2014
106 filings reported holding LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock as of Q2 2014.
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) has 99 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24M shares
of 37.4M outstanding shares and own 64.06% of the company stock.
Largest 10 shareholders include GUGGENHEIM CAPITAL LLC (2.57M shares), ARIEL INVESTMENTS, LLC (2.41M shares), DIMENSIONAL FUND ADVISORS LP (2.13M shares), Opus Capital Group, LLC (1.95M shares), WYNNEFIELD CAPITAL INC (1.71M shares), KILLEN GROUP INC (1.31M shares), Boston Partners (939K shares), ROYAL BANK OF CANADA (926K shares), BlackRock Institutional Trust Company, N.A. (863K shares), and VANGUARD GROUP INC (791K shares).
This table shows the top 99 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.